Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].
BOSTON, MASSACHUSETTS, May 20, 2020 – Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections, today announced a $215 million Series D financing. The financing was led by Bain Capital Life Sciences and also included new investors RA Capital Management, Perceptive Advisors, Rock Springs...
IRVINE, California-JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic valve disease, announces that it has raised $50 million in an equity financing led by Bain Capital Life Sciences. Additional participants in the financing included existing investors Andera Partners, Gimv, Legend...
Emeryville, CA., August 12, 2019 – Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, today announced Andrew A. F. Hack, M.D., Ph.D., a Managing Director at Bain Capital Life Sciences, has been appointed to Dynavax’s Board of Directors. The appointment follows an investment by Bain Capital Life Sciences in Dynavax’s...
SOUTH SAN FRANCISCO, CA, December 19, 2018 - Annexon Biosciences, a clinical stage biopharmaceutical company focused on the development of novel therapeutics through inhibition of the classical complement pathway, today announced that it has closed a $75 million Series C financing. The financing was led by new investor Bain Capital Life Sciences, with participation by Surveyor Capital (a Citadel...
SAN DIEGO, November 29, 2018 – ViaCyte, Inc., a privately-held clinical stage regenerative medicine company, today announced an $80 million Series D financing led by Bain Capital Life Sciences and joined by TPG and RA Capital Management, as well as existing investor, Sanderling Ventures, and several individual supporters of the Company. Proceeds from the financing will be used to further...
BOSTON and NEW YORK, October 23, 2018 – Bain Capital, LP and Pfizer Inc. (NYSE: PFE) today announced the creation of Cerevel Therapeutics, LLC (“Cerevel”), a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS). Pfizer is contributing a portfolio of pre-commercial neuroscience assets to Cerevel, which include three...
LOWELL, MA, May 2, 2018 – Rapid Micro Biosystems, the leading provider of automated, growth-based, rapid microbial detection technology for the healthcare product manufacturing sector, announced that it has secured $60 million in equity financing led by new investors Bain Capital Life Sciences and Xeraya Capital. The new funding round also includes a commitment from another new investor, Asahi...
EVANSTON, ILLINOIS, December 18, 2017 – Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today is announcing the completion of a $70 million Series B financing to fund advancement of its expanding clinical-stage pipeline. The financing was led by Bain Capital Life Sciences. Additional new investors include Adage...
JENA, GERMANY, October 13, 2017 - InflaRx, the biopharmaceutical company developing new therapeutics in the terminal complement space, announced today a $ 55M Series D financing and investment round. The round was co-led by Bain Capital Life Sciences LP, Cormorant Asset Management LLC and RA Capital Management LLC and complemented by certain investment funds managed by a leading US investment...
NEW YORK, September 25, 2017 - SpringWorks Therapeutics, a mission-driven medicines company dedicated to developing innovative potential new treatments for underserved patient communities, announced its launch today with a completed $103 million Series A financing funded by Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer (NYSE:PFE) and LifeArc (formerly known as...
The @c2cboston Emergency Essentials Fund helps provide the most essential items to families in Massachusetts, such… https://t.co/PYgbUa2nPG
Newsweek named @DanaFarber the third best hospital for oncology globally. Read the news release for the full story. https://t.co/k6UKc1dFFI
There are two more weeks to ride for #RideforFood with @communityserv. Learn more or register now. https://t.co/pRTsVYQXwF
The #PMC2020 weekend may be over, but you can still support a rider and cancer research @DanaFarber. Learn more. https://t.co/tsNP5lTKgg
A study by ICF Inc. shows that for every $1 invested in programs like @CityYear and AmeriCorps members, the total r… https://t.co/UKtlORbOQ0
Teamwork and resiliency are two qualities of successful athletes. They are also skills of effective @CityYear Ameri… https://t.co/v9RUMYO1ms
Manda Wittenbort was driven to a career of civic service, starting with national service with @CityYear. Read the f… https://t.co/7vdlS2Cu6A
Register for the virtual 2020 PMC Kids Rides and join the fight against cancer. #PMCkids https://t.co/qs1tnHn0n0
Paola Garcia’s personal experiences inspired her to pursue a career with @YearUp. Read the full blog post. https://t.co/pVXK1uXFL3
Help the restaurant community in Boston recover by #dininginbos. Learn more. https://t.co/Sw8yiq0KDi